Allergic bronchopulmonary aspergillosis: XXI century. A modern view on the problem

Journal Title: Астма и Аллергия - Year 2018, Vol 1, Issue 4

Abstract

Aspergillus organisms are widely ubiquitous in the environment and can cause a great number of pathological syndromes mainly in immunocom ­ promised patients . However , aspergillosis lesion may occur not only in patients with immunodeficiency . Allergic bronchopulmonary aspergillosis is a noninvasive form of Aspergillus lung disease , occurring in nonimmunocompromised patients and manifesting with poorly controlled severe asthma . The pathogenesis of this disease is not understood completely . But there are a lot of investigations those can shed the light on some mechanisms of disease development . The diagnosis is based on results of different tests such as aspergillus skin ­ test , total and specific serum IgE levels , specific se ­ rum IgG levels , high ­ resolution computed tomography , investigation of sputum culture etc . Based on typical symptoms and data of laboratory and instrumental methods , diagnostic criteria were formulated . Purposes of treatment includes asthma control , prevention and treatment of exacerbations , prevention of bronchiectasis development . The basic principles of treatment are immunosuppression and eradication of the pathogen from the or ­ ganism . Oral and inhaled corticosteroids , antifungal drugs and anti ­ IgE monoclonal antibodies are used . But there are not official recommendations about dosage , drug regimen and duration of treatment . Therefore , treatment options described in different works are based on individual experience of patient management . The development of molecular allergology opens new perspectives for diagnosis and treatment of this disease . New antigenic components of A . fumigatus are released and new vaccine for antigen ­ specific immunotherapy are developed . But efficiency and expediency of this diagnostic and treatment method need to be investigated

Authors and Affiliations

T. O. Pertseva, K. Yu. Gashynova, D. O. Sokur

Keywords

Related Articles

EVALUATION OF THE EFFICACY AND SAFETY OF COMBINED USE OF FORMOTEROL AND FLUTICASONE PROPIONATE IN THE TREATMENT OF PATIENTS WITH BRON-CHIAL ASTHMA AND COMORBID CORONARY HEART DISEASE

TAim: to evaluate the clinical efficacy and safety of the use of formoterol (Zafiron medicine, «Adamed Pharma S.A» pharmaceutical company) and fluticasone propionate (Flutixon medicine, «Adamed Pharma S.A» ph...

DIFFERENT METHODS OF DERMATOPHAGOIDES FARINAE SENSITIZATION DETERMINATION IN PATIENTS WITH RESPIRATORY ALLERGY

Objective was to study and compare the parameters of the specificity and sensitivity of skin testing and serologic determination of specific Dermatophagoides farinae IgE. Materials and methods . 88 patients with aller...

SEVERE COURSE OF BRONCHIAL ASTHMA PROGNOSING

Aim of study – to carry out prognоsis of the influence of risk factors on uncontrolled course of bronchial asthma (BA), decrease of tolerance to physical activity, deterioration of quality of life, development of lung hy...

DECAMETHOXIN: NEBULIZER THERAPY OF INFECTIOUS EXACERBATION OF CHRONIC BRONCHITIS

Exacerbation of chronic bronchitis (CB) is a risk factor for death, hospitalizations, respiratory symptoms worsening, limitation of physical activity and disability of the patients. The causes of 60 to 80 %...

DYSPNEA: FROM THE SYSTEM OF VIEWS TO DIAGNOSIS

The paper describes the issues of etiopathogenesis and diagnostics of dyspnea and respiratory failure. According to the American Thoracic Society, in the United States annually more than 17 million people v...

Download PDF file
  • EP ID EP462785
  • DOI 10.31655/2307-3373-2018-4-29-36
  • Views 157
  • Downloads 0

How To Cite

T. O. Pertseva, K. Yu. Gashynova, D. O. Sokur (2018). Allergic bronchopulmonary aspergillosis: XXI century. A modern view on the problem. Астма и Аллергия, 1(4), 29-36. https://europub.co.uk/articles/-A-462785